GXMC
RARE icon

Global X Management Company’s Ultragenyx Pharmaceutical RARE Stock Holding History

Global X Management Company’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$67K Buy
878
+356
+68% +$23K ﹤0.01% 1049
2018
Q1 		$27K Buy
522
+22
+4% +$1.11K ﹤0.01% 1096
2017
Q4 		$23K Buy
500
+127
+34% +$6.23K ﹤0.01% 1019
2017
Q3 		$20K Buy
373
+11
+3% +$652 ﹤0.01% 1066
2017
Q2 		$22K Buy
362
+29
+9% +$1.75K ﹤0.01% 1135
2017
Q1 		$23K Buy
+333
New +$25.4K ﹤0.01% 1049

Other funds holding RARE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return